The U.S. Justice Department claims the wholesale drug distributor failed to report more than 12,000 retail pharmacy orders to the DEA since 2014.
As part of the settlement, Morris & Dickson also agreed to spend millions of dollars to hire staff and improve its oversight of controlled substances.
Morris & Dickson did not admit any wrongdoing. However, the company told CNBC, “the opioid crisis is real, and we unequivocally accept our responsibility to do everything in our control as a distributor to prevent misuse — while also protecting deserving patients’ ability to receive the doctor-prescribed medications they absolutely need.”
More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck’s Keytruda fails late-stage trial as standalone treatment for breast cancer
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
